Discovery and Advancement of Farnesyl Transferase Inhibitors as Potential Anticancer Therapeutic Agents: SCH 66336 a Case Study
Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents · 2001
DOI: 10.2174/1568013013359104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents, 2001. Verfasst von F. Njoroge und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Njoroge, F., & Girijavallabhan, V. (2001). Discovery and Advancement of Farnesyl Transferase Inhibitors as Potential Anticancer Therapeutic Agents: SCH 66336 a Case Study. Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents. https://doi.org/10.2174/1568013013359104
Vancouver
Njoroge F, Girijavallabhan V. Discovery and Advancement of Farnesyl Transferase Inhibitors as Potential Anticancer Therapeutic Agents: SCH 66336 a Case Study. Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents. 2001. doi:10.2174/1568013013359104
BibTeX
@article{Njoroge2001,
author = {Njoroge, F. and Girijavallabhan, Viyyoor},
title = {Discovery and Advancement of Farnesyl Transferase Inhibitors as Potential Anticancer Therapeutic Agents: SCH 66336 a Case Study},
journal = {Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents},
year = {2001},
doi = {10.2174/1568013013359104}
}
EUVIMED